Evidence map›Paper›PMID 36623778›Full record

ArticleGastroenterology2023

Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric Catechol-O-Methyltransferase/microRNA-155/Tumor Necrosis Factor α Axis.

QiQi Zhou, Liuqing Yang, Meghan L Verne, Benjamin B Zhang, Jeremy Fields, George Nicholas Verne

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

QiQi ZhouDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee; Memphis Veterans Affairs Medical Center, Research Service, Memphis, Tennessee.
Liuqing YangDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Meghan L VerneDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Benjamin B ZhangDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Jeremy FieldsDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
George Nicholas VerneDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee; Memphis Veterans Affairs Medical Center, Research Service, Memphis, Tennessee. Electronic address: gverne@tennessee.edu.
University of Tennessee Health Science Center · US

Funding

Mechanisms of Altered Gastrointestinal DysfunctionR01DK099052 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI VERNE, GEORGE NICHOLAS, ZHOU, QIQI · 2013 to 2023
$3.0M
Mechanisms of Gastrointestinal Post-Inflammatory DiseaseR01DK118959 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI VERNE, GEORGE NICHOLAS, ZHOU, QIQI · 2019 to 2022
$1.4M
CSRD VA I01 CX001477NIDDK NIH HHS R01 DK099052NIDDK NIH HHS R01 DK118959
6 · The paper itself

Abstract

BACKGROUND &

aimsThe etiology of abdominal pain in postinfectious, diarrhea-predominant irritable bowel syndrome (PI-IBS-D) is unknown, and few treatment options exist. Catechol-O-methyltransferase (COMT), an enzyme that inactivates and degrades biologically active catecholamines, plays an important role in numerous physiologic processes, including modulation of pain perception. Our objective was to determine the mechanism(s) of how decreased colonic COMT in PI-IBS-D patients contributes to the chronic abdominal pain phenotype after enteric infections.

methodsColon neurons, epithelial cells, and macrophages were procured with laser capture microdissection from PI-IBS-D patients to evaluate cell-specific colonic COMT, microRNA-155 (miR-155), and tumor necrosis factor (TNF) α expression levels compared to recovered patients (infection cleared: did not develop PI-IBS-D) and control individuals. COMT

resultsColonic COMT levels were significantly decreased and correlated with increased visual analog scale abdominal pain ratings in PI-IBS-D patients compared to recovered patients and control individuals. Colonic miR-155 and TNF-α were increased in PI-IBS-D patients with diminished colonic COMT. COMT

conclusionsDecreased colonic COMT in PI-IBS-D patients drives abdominal pain phenotypes via the COMT/miR-155/TNF-α axis. These important findings will allow new treatment paradigms and more targeted and personalized medicine approaches for gastrointestinal disorders after enteric infections.

Indexed as

Irritable Bowel SyndromeMicroRNAsAbdominal PainAnimalsCatechol O-MethyltransferaseColonHumansMiceNociceptionSulfonic AcidsTrinitrobenzenesTumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsCatechol O-MethyltransferaseMicroRNAsMIRN155 microRNA, humanMirn155 microRNA, mouseSulfonic AcidsTrinitrobenzenesTumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsAbdominal PainCatechol-O-MethyltransferaseIrritable Bowel SyndromeVisceral Hypersensitivity

Identifiers

PMID36623778
PMCPMC10038873
OpenAlexW4313647525

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.